• Explore /
  • Poster
  • / Updated survival date of phase I/II study of carboplatin plus nab-paclitaxel and concurrent radiotherapy for patients with locally advanced non-small cell lung cancer.

Updated survival date of phase I/II study of carboplatin plus nab-paclitaxel and concurrent radiotherapy for patients with locally advanced non-small cell lung cancer.

Abstract Poster

Authors

null

Atsushi Horiike

Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan

Atsushi Horiike , Yuko Kawano , Tomonari Sasaki , Hiroyuki Yamaguchi , Katsuya Hirano , Miyako Satouchi , Shinobu Hosokawa , Ryotaro Morinaga , Kazutoshi Komiya , Koji Inonue , Yuka Fujita , Ryo Toyozawa , Tomoki Kimura , Kosuke Takahashi , Kazuo Nishikawa , Junji Kishimoto , Yoichi Nakanishi , Isamu Okamoto

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Track

Lung Cancer

Sub Track

Local-Regional Non–Small Cell Lung Cancer

Clinical Trial Registration Number

UMIN000012719

Citation

J Clin Oncol 37, 2019 (suppl; abstr 8529)

DOI

10.1200/JCO.2019.37.15_suppl.8529

Abstract #

8529

Poster Bd #

285

Abstract Disclosures

Similar Posters

First Author: Astrid Paulus

First Author: A. P. Kotsakis

First Author: Yasutaka Watanabe

First Author: Elisa María Fernández Pérez